171 related articles for article (PubMed ID: 25399714)
21. [Pharmacogenetic aspects of current pharmacotherapy].
Slanar O; Zima T
Cas Lek Cesk; 2010; 149(10):472-5. PubMed ID: 21121137
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetic screening for drug therapy: from single gene markers to decision making in the next generation sequencing era.
Tzvetkov M; von Ahsen N
Pathology; 2012 Feb; 44(2):166-80. PubMed ID: 22228255
[TBL] [Abstract][Full Text] [Related]
23. Current applications of clinical genetic testing for psychiatric practice.
Mrazek DA
Minn Med; 2007 Jan; 90(1):42-3. PubMed ID: 17305105
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
de Leon J; Arranz MJ; Ruaño G
Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics and cost-effectiveness analysis: a two-way street.
Chalkidou K; Rawlins M
Drug Discov Today; 2011 Oct; 16(19-20):873-7. PubMed ID: 21903176
[TBL] [Abstract][Full Text] [Related]
26. Risk assessment and pharmacogenetics in molecular and genomic epidemiology.
Park SK; Choi JY
J Prev Med Public Health; 2009 Nov; 42(6):371-6. PubMed ID: 20009483
[TBL] [Abstract][Full Text] [Related]
27. Considerations for safety pharmacogenetics in clinical practice.
Frueh FW
Drug Discov Today; 2011 Oct; 16(19-20):898-901. PubMed ID: 21888988
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetics and anaesthesia: the value of genetic profiling.
Landau R; Bollag LA; Kraft JC
Anaesthesia; 2012 Feb; 67(2):165-79. PubMed ID: 22251108
[TBL] [Abstract][Full Text] [Related]
29. Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.
Bromley CM; Close S; Cohen N; Favis R; Fijal B; Gheyas F; Liu W; Lopez-Correa C; Prokop A; Singer JB; Snapir A; Tchelet A; Wang D; Goldstaub D;
Pharmacogenomics J; 2009 Feb; 9(1):14-22. PubMed ID: 18794908
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics and personalised medicine: maintain a critical approach.
Prescrire Int; 2013 Jun; 22(139):161-3. PubMed ID: 23866362
[TBL] [Abstract][Full Text] [Related]
31. How genetic variation affects patient response and outcome to therapy for psoriasis.
Woolf RT; Smith CH
Expert Rev Clin Immunol; 2010 Nov; 6(6):957-66. PubMed ID: 20979559
[TBL] [Abstract][Full Text] [Related]
32. Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.
Frieling H; Tadić A
Int Rev Psychiatry; 2013 Oct; 25(5):572-8. PubMed ID: 24151802
[TBL] [Abstract][Full Text] [Related]
33. Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity.
Hertz DL; McLeod HL
J Hum Genet; 2013 Jun; 58(6):346-52. PubMed ID: 23677053
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacogenetics in future medical care -- implications for patients and physicians].
Rogausch A; Brockmöller J; Himmel W
Gesundheitswesen; 2005 Apr; 67(4):257-63. PubMed ID: 15856385
[TBL] [Abstract][Full Text] [Related]
35. Patients' and physicians' perspectives on pharmacogenetic testing.
Rogausch A; Prause D; Schallenberg A; Brockmöller J; Himmel W
Pharmacogenomics; 2006 Jan; 7(1):49-59. PubMed ID: 16354124
[TBL] [Abstract][Full Text] [Related]
36. The laboratory's role in pharmacogenetic testing.
Oleschuck C
MLO Med Lab Obs; 2008 May; 40(5):14-9. PubMed ID: 18567490
[No Abstract] [Full Text] [Related]
37. Pharmacogenetics: using DNA to optimize drug therapy.
Lanfear DE; McLeod HL
Am Fam Physician; 2007 Oct; 76(8):1179-82. PubMed ID: 17990842
[TBL] [Abstract][Full Text] [Related]
38. The potential utility of pharmacogenetic testing in psychiatry.
Gardner KR; Brennan FX; Scott R; Lombard J
Psychiatry J; 2014; 2014():730956. PubMed ID: 25587529
[TBL] [Abstract][Full Text] [Related]
39. Unexpected High Need for Genetic Testing in Rheumatology: A Cross-Sectional Cohort Study.
Kampik L; Schirmer M
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895207
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the PharmGKB knowledge base as a resource for efficiently assessing the clinical validity and utility of pharmacogenetic assays.
Kawamoto K; Orlando LA; Voora D; Lobach DF; Joy S; Cho A; Ginsburg GS
AMIA Annu Symp Proc; 2009 Nov; 2009():307-11. PubMed ID: 20351870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
